This article is more than 5 years old. Information may no longer be current.

Top 4 breaking news stories this week

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The most frequently read breaking ophthalmology news stories on Healio.com this week included topics such as the Travatan approval for pediatric patients in Europe and the Carl Zeiss Meditec collaboration with Oraya Therapeutics.

Here are the top 4 most-viewed stories from Dec. 26 to Jan. 2:

1. MANF receives orphan drug designation for retinitis pigmentosa

MANF, an investigational drug, has received orphan drug designation for the treatment of retinitis pigmentosa from the U.S. Food and Drug Administration. Read more

2. Travatan approved in EU for pediatric glaucoma patients

The European Commission has granted Travatan eye drop solution an additional indication to treat pediatric patients with ocular hypertension or pediatric glaucoma. Read more

3. Carl Zeiss Meditec to collaborate with Oraya Therapeutics

Carl Zeiss Meditec has agreed to collaborate with Oraya Therapeutics and invest in the company’s low-energy radiotherapy treatment for wet age-related macular degeneration. Read more

4. Rescan 700 intraoperative OCT cleared by FDA

The Rescan 700 intraoperative optical coherence tomography system has received clearance from the U.S. Food and Drug Administration. Read more